Education

  • George Mason University, J.D.
  • University of North Carolina at Chapel Hill, Postdoctoral Fellow
  • East Carolina University School of Medicine, Ph.D., Pharmacology
  • Old Dominion University, B.S., Biochemistry

Bar Admissions

  • District of Columbia
  • U.S. Patent and Trademark Office
Who We Are

Tu Phan-Kerr, Ph.D.

Summary of Ferring B.V. v. Watson Laboratories, Inc. et al., 2014-1416
Summary of AbbVie, Inc., et al., v. The Mathilda & Terrence Kennedy Institute of Rheumatology Trust, 2013-1545
Summary of Cordis Corp. v. Boston Scientific Corp., 2010-1311
Kappa-opioid receptor antisense oligonucleotide injected into rat hippocampus causes hypertension, Eur. J. Pharmacol., 377(1): 57-61 (1999). (publication)
Autoradiographic evidence that intrastriatal administration of adenosine A1 receptor antisense oligodeoxynucleotide decreases adenosine A1 receptors in the rat striatum and cortex, Brain Res. Mol. Brain Res., 72(2), 226-230 (1999). (publication)
Intrastriatal adenosine A1 receptor antisense oligodeoxynucleotide inhibits striatal and cortical adenosine A1 receptor. Experimental Biology '98, San Francisco, CA, April 1998. (publication)
Intrastriatal adenosine A1 receptor antisense oligodeoxynucleotide blocks ethanol-induced motor incoordination, Eur. J. Pharmacol., 323(2/3), R5-R7 (1997). (publication)
Pharmacologic enhancement of random skin flap survival by prostaglandin E2, Arch. Otolaryngol. Head Neck Surg., 120, 56-60 (1994). (publication)
Changes in Striatal D2 Receptor Binding in Post-Mortem Rat Brain, North Carolina Chapter of the Society for Neuroscience Annual Neuroscience Day, Durham, NC, 1994. (publication)
Long-term pretreatment with pentoxifylline increases random skin flap survival, Arch. Otolaryngol. Head Neck Surg., 120, 65-71. (publication)